Giada Buffi

Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate

Anna Kabanova, Immaculada Margarit, Francesco Berti et al. · Vaccine · 2010 · 92 citations

Vaccination, Reverse Vaccinology, Vaccine Development +8

Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial

Geeta K. Swamy, Torri D. Metz, Kathryn M. Edwards et al. · Vaccine · 2020 · 59 citations · Full text

Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes

Despo Chatzikleanthous, S. Schmidt, Giada Buffi et al. · Journal of Controlled Release · 2020 · 43 citations

Vaccination, Nanoparticles, Cross-protection +11

Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial

Geert Leroux‐Roels, Zourab Bebia, Cathy Maes et al. · Clinical Infectious Diseases · 2019 · 32 citations · Full text

Immune Response to Invasive Group B<i>Streptococcus</i>Disease in Adults

Morven S. Edwards, Marcia A. Rench, C. Daniela Rinaudo et al. · Emerging infectious diseases · 2016 · 21 citations · Full text

Vaccination, Medical Microbiology, Pilus Island +11